Skip to main content
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1962 Jun;41(6):1277–1287. doi: 10.1172/JCI104590

ACTIVE HAGEMAN FACTOR: A PLASMA LYSOKINASE OF THE HUMAN FIBRINOLYTIC SYSTEM*

Sotirios G Iatridis 1, John H Ferguson 1
PMCID: PMC291042  PMID: 14450472

Full text

PDF
1277

Images in this article

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALKJAERSIG N., FLETCHER A. P., SHERRY S. The activation of human plasminogen. I. Spontaneous activation in glycerol. J Biol Chem. 1958 Jul;233(1):81–85. [PubMed] [Google Scholar]
  2. ALKJAERSIG N., FLETCHER A. P., SHERRY S. xi-Aminocaproic acid: an inhibitor of plasminogen activation. J Biol Chem. 1959 Apr;234(4):832–837. [PubMed] [Google Scholar]
  3. ASTRUP T. Fibrinolysis in the organism. Blood. 1956 Sep;11(9):781–806. [PubMed] [Google Scholar]
  4. ASTRUP T., MULLERTZ S. The fibrin plate method for estimating fibrinolytic activity. Arch Biochem Biophys. 1952 Oct;40(2):346–351. doi: 10.1016/0003-9861(52)90121-5. [DOI] [PubMed] [Google Scholar]
  5. ASTRUP T., STERNDORFF I. Fibrinolysokinase activity in animal and human tissue. Acta Physiol Scand. 1956 Jul 17;37(1):40–47. doi: 10.1111/j.1748-1716.1956.tb01340.x. [DOI] [PubMed] [Google Scholar]
  6. BECKER E. L. Inactivation of Hageman factor by diisopropylfluorophosphate (DFP). J Lab Clin Med. 1960 Jul;56:136–138. [PubMed] [Google Scholar]
  7. FERGUSON J. H., WILSON E. G., IATRIDIS S. G., RIERSON H. A., JOHNSTON B. R. Enzymes and blood clotting. I. Trypsin as an accessory factor. J Clin Invest. 1960 Dec;39:1942–1952. doi: 10.1172/JCI104219. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. HARDISTY R. M., MARGOLIS J. The role of Hageman factor in the initiation of blood coagulation. Br J Haematol. 1959 Apr;5(2):203–211. doi: 10.1111/j.1365-2141.1959.tb04026.x. [DOI] [PubMed] [Google Scholar]
  9. JOHNSTON C. L., Jr, FERGUSON J. H., O'HANLON F. A. Surface activation of plasma clotting: a function of Hageman factor. Proc Soc Exp Biol Med. 1958 Oct;99(1):197–201. doi: 10.3181/00379727-99-24294. [DOI] [PubMed] [Google Scholar]
  10. KLINE D. L. The purification and crystallization of plasminogen (profibrinolysin). J Biol Chem. 1953 Oct;204(2):949–955. [PubMed] [Google Scholar]
  11. KWAAN H. C., LO R., MCFADZEAN A. J. On the production of plasma fibrinolytic activity within veins. Clin Sci. 1957 May;16(2):241–253. [PubMed] [Google Scholar]
  12. KWAAN H. C., LO R., McFADZEAN A. J. On the inhibition of plasma fibrinolytic activity by exercised ischaemic muscles. Clin Sci. 1958;17(2):361–368. [PubMed] [Google Scholar]
  13. KWAAN H. C., LO R., McFADZEAN J. S. On the lysis of thrombi experimentally produced within veins. Br J Haematol. 1958 Jan;4(1):51–62. doi: 10.1111/j.1365-2141.1958.tb03833.x. [DOI] [PubMed] [Google Scholar]
  14. LEWIS J. H., FERGUSON J. H. Studies on a proteolytic enzyme system of the blood. Activation of profibrinolysin by serum fibrinolysokinase. Proc Soc Exp Biol Med. 1951 Oct;78(1):184–188. doi: 10.3181/00379727-78-19014. [DOI] [PubMed] [Google Scholar]
  15. MULLERTZ S. Activation of plasminogen. Ann N Y Acad Sci. 1957 Aug 30;68(1):38–51. doi: 10.1111/j.1749-6632.1957.tb42611.x. [DOI] [PubMed] [Google Scholar]
  16. MULLERTZ S. Formation and properties of the activator of plasminogen and of human and bovine plasmin. Biochem J. 1955 Nov;61(3):424–434. doi: 10.1042/bj0610424. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. NIEWIAROWSKI S., PROU-WARTELLE O. [Role of the contact factor (Hageman factor) in fibrinolysis]. Thromb Diath Haemorrh. 1959 Sep 1;3:593–603. [PubMed] [Google Scholar]
  18. RATNOFF O. D., DAVIE E. W., MALLETT D. L. Studies on the action of Hageman factor: evidence that activated Hageman factor in turn activates plasma thromboplastin antecedent. J Clin Invest. 1961 May;40:803–819. doi: 10.1172/JCI104314. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. SAWYER W. D., FLETCHER A. P., ALKJAERSIN N., SHERRY S. Studies on the thrombolytic activity of human plasma. J Clin Invest. 1960 Feb;39:426–434. doi: 10.1172/JCI104054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. SHERRY S., FLETCHER A. P., ALKJAERSIG N. Fibrinolysis and fibrinolytic activity in man. Physiol Rev. 1959 Apr;39(2):343–382. doi: 10.1152/physrev.1959.39.2.343. [DOI] [PubMed] [Google Scholar]
  21. SOULIER J. P., WARTELLE O., MENACHE D. Caractères différentiels des facteurs Hageman et P.T.A. ; rôle du contact dans la phase initiale de la coagulation. Rev Fr Etud Clin Biol. 1958 Mar;3(3):263–267. [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES